183 related articles for article (PubMed ID: 10543720)
1. Lipoprotein lipase activity is stimulated by insulin and dexamethasone in cardiomyocytes from diabetic rats.
Ewart HS; Carroll R; Severson DL
Can J Physiol Pharmacol; 1999 Aug; 77(8):571-8. PubMed ID: 10543720
[TBL] [Abstract][Full Text] [Related]
2. Heparin-releasable lipoprotein lipase activity is increased in cardiomyocytes after culture.
Anderson LG; Carroll R; Acharya A; Severson DL
Can J Physiol Pharmacol; 1998 Feb; 76(2):229-36. PubMed ID: 9635164
[TBL] [Abstract][Full Text] [Related]
3. Insulin and dexamethasone stimulation of cardiac lipoprotein lipase activity involves the actin-based cytoskeleton.
Ewart HS; Severson DL
Biochem J; 1999 Jun; 340 ( Pt 2)(Pt 2):485-90. PubMed ID: 10333493
[TBL] [Abstract][Full Text] [Related]
4. Lipoprotein lipase activity in rat cardiomyocytes is stimulated by insulin and dexamethasone.
Ewart HS; Carroll R; Severson DL
Biochem J; 1997 Oct; 327 ( Pt 2)(Pt 2):439-42. PubMed ID: 9359413
[TBL] [Abstract][Full Text] [Related]
5. Acute dexamethasone-induced increase in cardiac lipoprotein lipase requires activation of both Akt and stress kinases.
Kewalramani G; Puthanveetil P; Kim MS; Wang F; Lee V; Hau N; Beheshti E; Ng N; Abrahani A; Rodrigues B
Am J Physiol Endocrinol Metab; 2008 Jul; 295(1):E137-47. PubMed ID: 18460599
[TBL] [Abstract][Full Text] [Related]
6. Acute intralipid infusion reduces cardiac luminal lipoprotein lipase but recruits additional enzyme from cardiomyocytes.
Qi D; Kuo KH; Abrahani A; An D; Qi Y; Heung J; Kewalramani G; Pulinilkunnil T; Ghosh S; Innis SM; Rodrigues B
Cardiovasc Res; 2006 Oct; 72(1):124-33. PubMed ID: 16934788
[TBL] [Abstract][Full Text] [Related]
7. Insulin stimulates lipoprotein lipase activity and synthesis in adipocytes from septic rats.
Rosato EF; Vemulapalli P; Lang CH; Lanza-Jacoby S
J Surg Res; 1997 Nov; 73(1):73-9. PubMed ID: 9441796
[TBL] [Abstract][Full Text] [Related]
8. Endothelial binding sites for lipoprotein lipase are not diminished in perfused hearts from diabetic rats.
Liu L; Severson DL
Can J Physiol Pharmacol; 1996 Nov; 74(11):1204-9. PubMed ID: 9028578
[TBL] [Abstract][Full Text] [Related]
9. Fatty acids reduce heparin-releasable LPL activity in cultured cardiomyocytes from rat heart.
Anderson LG; Carroll R; Ewart HS; Acharya A; Severson DL
Am J Physiol; 1997 Oct; 273(4):E759-67. PubMed ID: 9357806
[TBL] [Abstract][Full Text] [Related]
10. Metabolism of very-low-density lipoprotein and chylomicrons by streptozotocin-induced diabetic rat heart: effects of diabetes and lipoprotein preference.
Niu YG; Evans RD
Am J Physiol Endocrinol Metab; 2008 Nov; 295(5):E1106-16. PubMed ID: 18780778
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of streptozotocin-induced diabetes on cardiac lipoprotein lipase activity.
Rodrigues B; Cam MC; Jian K; Lim F; Sambandam N; Shepherd G
Diabetes; 1997 Aug; 46(8):1346-53. PubMed ID: 9231661
[TBL] [Abstract][Full Text] [Related]
12. Myocardial lipoprotein lipase activity: regulation by diabetes and fructose-induced hypertriglyceridemia.
Liu L; Severson DL
Can J Physiol Pharmacol; 1995 Mar; 73(3):369-77. PubMed ID: 7648516
[TBL] [Abstract][Full Text] [Related]
13. A transcription-dependent mechanism, akin to that in adipose tissue, modulates lipoprotein lipase activity in rat heart.
Wu G; Zhang L; Gupta J; Olivecrona G; Olivecrona T
Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E908-15. PubMed ID: 17595214
[TBL] [Abstract][Full Text] [Related]
14. The metabolic "switch" AMPK regulates cardiac heparin-releasable lipoprotein lipase.
An D; Pulinilkunnil T; Qi D; Ghosh S; Abrahani A; Rodrigues B
Am J Physiol Endocrinol Metab; 2005 Jan; 288(1):E246-53. PubMed ID: 15328075
[TBL] [Abstract][Full Text] [Related]
15. beta-Agonist stimulation produces changes in cardiac AMPK and coronary lumen LPL only during increased workload.
An D; Kewalramani G; Qi D; Pulinilkunnil T; Ghosh S; Abrahani A; Wambolt R; Allard M; Innis SM; Rodrigues B
Am J Physiol Endocrinol Metab; 2005 Jun; 288(6):E1120-7. PubMed ID: 15687106
[TBL] [Abstract][Full Text] [Related]
16. Streptozotocin-induced diabetes enhances cardiac heparin-releasable lipoprotein lipase activity in spontaneously hypertensive rats.
Shepherd G; Cam MC; Sambandam N; Abrahani MA; Rodrigues B
Hypertension; 1998 Mar; 31(3):878-84. PubMed ID: 9495276
[TBL] [Abstract][Full Text] [Related]
17. Cardiac lipoprotein lipase: metabolic basis for diabetic heart disease.
Pulinilkunnil T; Rodrigues B
Cardiovasc Res; 2006 Feb; 69(2):329-40. PubMed ID: 16307734
[TBL] [Abstract][Full Text] [Related]
18. Comparison of heparin-releasable lipase and tissue neutral lipase activity of rat heart.
Stam H; Hülsmann WC
Biochem Int; 1983 Aug; 7(2):187-95. PubMed ID: 6679339
[TBL] [Abstract][Full Text] [Related]
19. Determination of lipoprotein lipase activity in post heparin plasma of streptozotocin-induced diabetic rats by high-performance liquid chromatography with fluorescence detection.
Chou YC; Tsai YC; Chen CM; Chen SM; Lee JA
Biomed Chromatogr; 2008 May; 22(5):502-10. PubMed ID: 18205134
[TBL] [Abstract][Full Text] [Related]
20. Lipoprotein lipase release from cardiac myocytes is increased by decavanadate but not insulin.
Braun JE; Severson DL
Am J Physiol; 1992 May; 262(5 Pt 1):E663-70. PubMed ID: 1590376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
